Assessing Cerebrospinal Fluid Flow Dynamics in Pediatric Patients with Central Nervous System Tumors Treated with Intraventricular Radioimmunotherapy

J Nucl Med. 2020 May;61(5):662-664. doi: 10.2967/jnumed.119.232678. Epub 2020 Jan 31.

Abstract

The incidence of abnormal cerebrospinal fluid (CSF) flow dynamics in children with central nervous system (CNS) tumors before intraventricular therapy has not been described. Methods: We performed a single-institution, retrospective review of patients with primary or metastatic CNS tumors treated between 2003 and 2018 (15 y). Patients underwent 111In-diethylenetriaminepentaacetic acid injection into the CSF intraventricular space followed by nuclear medicine imaging at 90 min, 4 h, 24 h, and 48 h (if required). CSF flow was classified as normal, delayed, asymmetric, or obstructed. Results: In total, 278 CSF flow studies were performed on 224 patients, 202 of whom (90%) were less than 18 y old. Of these, 116 patients (52%) had metastatic CNS neuroblastoma, 57 (25%) had medulloblastoma, and 51 (23%) had other histologic types of CNS tumors. Of the 278 studies, 237 (85%) were normal, 9 (3%) required neurosurgical intervention, 25 (9%) were delayed, and 7 (3%) were asymmetric. Conclusion: Abnormal CSF flow and the necessity for neurosurgical intervention must be considered when attempting to ensure appropriate intraventricular therapy in the pediatric population.

Keywords: cerebrospinal flow; leptomeningeal disease; radioimmunotherapy.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Central Nervous System Neoplasms / cerebrospinal fluid
  • Central Nervous System Neoplasms / physiopathology*
  • Central Nervous System Neoplasms / radiotherapy*
  • Cerebrospinal Fluid / metabolism*
  • Humans
  • Hydrodynamics*
  • Injections, Intraventricular
  • Radioimmunotherapy*
  • Retrospective Studies